Presence of a malignant tumor positively diagnosed with histopathological confirmation and characterized by the uncontrolled growth of malignant cells with invasion and destruction of normal tissue. The term malignant tumor includes leukemia, lymphoma and sarcoma. The following are excluded under Major Cancer: 1) All tumors which are histologically classified as any of the following: a) Pre-malignant; b) Non-invasive; c) Carcinoma-in-situ(CIS); d) Having borderline malignancy; e) Having any degree of malignant potential; f) Having suspicious malignancy; g) Neoplasm of uncertain or unknown behavior; or h) Cervical Dysplasia CIN-1, CIN-2 and CIN-3 2) Any non-melanoma skin carcinoma unless there is evidence of metastases to lymph nodes or beyond; 3) Malignant melanoma that has not caused invasion beyond the epidermis; 4) All prostate cancers histologically described as T1N0M0 (TNM Classification) or below; or Prostate cancers of another equivalent or lesser classification; 5) All Thyroid cancers histologically classified as T1N0M0 (TNM Classification) or below; 6) All Tumors of the Urinary Bladder histologically classified as T1N0M0 (TNM Classification) or below; 7) All Gastro-Intestinal Stromal tumors histologically classified as T1N0M0 (TNM Classification) or below and with mitotic count of less than equal to 5/50 HPFs; 8) Chronic Lymphocytic Leukemia less the RAI Stage 3. 9) All tumors in the presence of HIV infection; or, 10) All tumors diagnosed before the policy inception date or the reinstatement date, whichever is later.